XML 35 R19.htm IDEA: XBRL DOCUMENT
v3.19.3

Financial Instruments | 9 Months Ended
--- | ---
Sep. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract] |
Financial Instruments | Note 12 – Financial Instruments Cash, cash equivalents and restricted cash The Company has cash that is legally restricted as to use or withdrawal. A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows:
|  | September 30, 2019 |  |  | December 31, 2018 |  |  | September 30, 2018 |  |  | December 31, 2017 |
Cash and cash equivalents presented in the consolidated condensed balance sheets |  | $ | 45,200 |  |  | $ | 39,620 |  |  | $ | 47,152 |  |  | $ | 103,172 |
Restricted cash |  |  | 2,504 |  |  |  | — |  |  |  | — |  |  |  | — |
Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows |  | $ | 47,704 |  |  | $ | 39,620 |  |  | $ | 47,152 |  |  | $ | 103,172 |
Derivative Financial Instruments We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $25,210 and $33,250 outstanding as of September 30, 2019 and December 31, 2018, respectively. The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. No commodity swap contracts were outstanding at September 30, 2019 or at December 31, 2018. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated statements of income. See Note 14 for the amount of unrealized loss associated with foreign currency derivatives previously reported in accumulated other comprehensive loss that was reclassified into earnings during 2019. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes. The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of September 30, 2019 is as follows:
|  |  |  |  |  | Asset Derivatives |  |  | Liability Derivatives |  |  |  |  |
|  | Hedge Designation |  | Fair Value Hierarchy |  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |  |  | Net Asset/ (Liabilities) |
Foreign currency derivatives |  | Cash flow hedge |  | Level 2 |  | Current assets |  | $ | 897 |  |  | Current liabilities |  | $ | — |  |  | $ | 897 |
Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:
|  | Location |  | Three Months Ended September 30, 2019 |  |  | Three Months Ended September 30, 2018 |  |  | Nine Months Ended September 30, 2019 |  |  | Nine Months Ended September 30, 2018 |
Foreign currency derivatives |  | Cost of sales |  | $ | 328 |  |  | $ | 391 |  |  | $ | 1,003 |  |  | $ | (214 | )
|  | Selling, general and administrative |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 75 |
|  | Other comprehensive income |  |  | (257 | ) |  |  | 1,753 |  |  |  | 806 |  |  |  | 2,304 |
|  | Foreign currency gain (loss) |  |  | 18 |  |  |  | 11 |  |  |  | (51 | ) |  |  | 58 |
Total foreign currency derivatives |  |  |  | $ | 89 |  |  | $ | 2,155 |  |  | $ | 1,758 |  |  | $ | 2,223 |
Commodity derivatives |  | Cost of sales |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 145 |
|  | Other comprehensive income |  |  | — |  |  |  | — |  |  |  | — |  |  | $ | (218 | )
Total commodity derivatives |  |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (73 | )
We did not incur any hedge ineffectiveness during the three and nine months ended September 30, 2019 and 2018.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration